Molecular aspects of esophageal squamous cell carcinoma carcinogenesis

Arquivos de Gastroenterologia

Volumn 40, Issue 4, 2003, Pages 256-261

  Lehrbach, Dárcio Matenhauer ^a   Nita, Marcelo Eidi ^a,b   Cecconello, Ivan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MYC PROTEIN; PROTEIN MDM2; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; CARCINOGENESIS; DNA METHYLATION; ESOPHAGUS CARCINOMA; HUMAN; ONCOGENE; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 2442585463     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032003000400011     Document Type: Review

References (44)

1. Anayama T, Furihata M, Takeuchi T, Sonobe H, Sasaguri S, Matsumoto M, Ohtsuki Y. Insufficient effect of p27(KIP1) to inhibit cyclin D1 in human esophageal cancer in vitro. Int J Oncol 2001;18:151-5.
2. Bahl R, Arora S, Nath N, Mathur M, Shukla NK, Ralhan R. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer. Oncogene 2000;19:323-8.
3. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-501.
4. Caron de Fromental C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 1992;4:1-15.
5. Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Kise Y, Kenmochi T, Himeno S, Machimura T, Tanaka M, Inokuchi S, Tajuma T, Osamura RY, Makuuchi H. Accumulation of p53 in esophageal squamous cell carcinoma. Int J Mol Med 2001;8:359-63.
6. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
7. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
8. Fujii S, Tominaga O, Nagawa H, Tsuno N, Nita ME, Tsuruo T, Muto T. Quantitative analysis of the cyclin expression in human esophageal cancer cell lines. J Exp Clin Cancer Res 1998;17:491-6.
9. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 1996;56:694-9.
10. Iamamura M. Prognostic significance of Cyclin D1 and E-cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. J Am Coll Surg 2001;192:708-18.
11. Ikeguchi M, Maeta M, Kaibara N. Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer. Int J Mol Med 2001;7:413-7.
12. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H, Nakajima T. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Res 2000;20:345-9.
13. Lam KY, Law S, Tung PH, Wong J. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med 2000;124:228-33.
14. Lane DP. p53, guardian of the genome. Nature 1992;358:15-6.
15. Lane DP. A death in the life of p53. Nature 1993;362:786-7.
16. Lebman DA, Edmiston JS, Chung TD, Snyder SR. Heterogeneity in the transforming growth factor beta response of esophageal cancer cells. Int J Oncol 2002;20:1241-6.
17. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998;16:1197-206.
18. Matsumoto M, Natsugoe S, Nakashima S, Okumura H, Sakita H, Baba M, Takao S, Aikou T. Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. Ann Surg Oncol 2001;8:598-604.
19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
20. Moraes-Filho J, Cecconello I, Gama-Rodrigues J, Castro L, Henry MA, Meneghelii UG, Quigey E, Brazilian Consensus Group. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol 2002;97:241-8.
21. Muñoz N. Epidemiological aspects of esophageal cancer. Endoscopy 1993; 23:609-12.
22. Nagasawa S, Masahiko O, Sasajima K, Makino H, Yamashita K, Takubo K, Miyashita M. Cyclin D1 over expression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol 2001;78:208-14.
23. Nita ME, Nagawa H, Tominaga O, Tsuno N, Hatano K, Kitayama J, Tsuruo T, Domene CE, Muto T. p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Ann Surg Oncol 1999;6:481-8.
24. Nita ME. Role of apoptosis related proteins in digestive tract cancer [thesis]. Tokyo: The University of Tokyo; 2000.
25. Nita ME, Ono-Nita SK, Tsuno N, Tominaga O, Takenoue T, Sunami E, Kitayama J, Nakamura Y, Nagawa H. Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil. Jpn J Cancer Res 2000;91:825-32.
26. Ohbu M, Saegusa M, Kobayashi N, Tsukamoto H, Mieno H, Kakita A, Okayasu I. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 1997;79:1287-93.
27. Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui C-H, Sherr CJ, Beach D, Look AT, Downing JR. Frequent deletion of p16(INK4a)/MTS1 and p15(INK4b)/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995;85:2321-30.
28. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3.
29. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F. A truncated -catenin disrupts the interaction between E-cadherin and -catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994;54:6282-7.
30. Pennisi E. How a growth control path takes a wrong turn to cancer. Science 1998;281:1438-41.
31. Polyak K, Lee M-H, Erdjumment-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
32. Ralhan R, Mathew R, Arora S, Bahl R, Shukla NK, Mathur M. Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 2000;126:655-60.
33. Ribeiro U, Finkelstein SD, Safatle-Ribeiro AV, Landreneau RJ, Clarke MR, Bakker A, Swalsky PA, Gooding WE, Posner MC. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 1998;83:7-18.
34. Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM, McCormick F, Korn WM. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant d11520 (ONYX-015). Nat Med 2001;6:1128-33.
35. Robertson KD, Jones PA. Tissue-specific alternative splicing in the human INK4a/ ARF cell cycle regulatory locus. Oncogene 1999;18:3810-20.
36. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
37. Si HX, Tsao SW, Lam KY, Srivastava G, Liu Y, Wong YC, Shen ZY, Cheung ALM. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Letters 2001;173:71-8.
38. Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T, Wolff G, Hauptmann S, Dorken B, Daniel PT. Analysis of 53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis. J Clin Oncol 2001;19:2272-81.
39. Tanaka H, Shimada Y, Imamura M, Shibagaki I, Ishizaki K. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Int J Cancer 1997;70:437-42.
40. Tetsu O, McCormick F. β-catenina regulates expression of ciclyn D1 in colon carcinoma cells. Nature 1999;398:422-6.
41. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
42. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999;5:2704-13.
43. Xing EP, Nie Y, Wang LD, Yang GY, Yang CS. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis 1999;20:77-84.
44. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-supressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995;92:7416-9.